Keratoconus, progressive myopia, and development of cystoid macular edema are areas of major unmet medical need.  iVeena is developing two platform technologies in cornea and cataract — including topical delivery of copper and drug delivery from the lens capsule respectively.  These novel approaches provide impactful and minimally invasive solutions for patients and physicians.

Pharmaceutical

iVeena

iVeena's headquarters in Salt Lake City, UT, United States

Gerald Simmons

Sarah Molokhia

Michael Burr

Ned Weinshenker

Edward Holland

Barry Hanover

Ron Heffernan

Jay Ambati

Paul M. Karpecki

Robert Dempsey

Stephen Christiansen

Richard Lindstrom

Vance Thompson

Jerry Hu

The Research & Development Team at iVeena focuses on advancing innovative medical solutions for ocular conditions like keratoconus and progressive myopia. Comprising seasoned scientific advisors and leaders, the team conducts cutting-edge research to develop and refine platform technologies for effective drug delivery systems, ensuring impactful and minimally invasive treatment options that meet critical patient needs.

Research & Development Team

The Leadership Team at iVeena is responsible for strategizing and guiding the company's vision and operations in developing innovative treatments for eye conditions like keratoconus and progressive myopia. This team, comprised of Vice Presidents in Product Development and Research, along with Chief Operating Officers, collaborates to drive product strategy, oversee research initiatives, and ensure the successful execution of groundbreaking treatments that address significant unmet medical needs in ophthalmology.

Leadership Team

iVeena

Org chart

Board & advisors

Teams

Research & Development Team

Leadership Team

Offices

iVeena

Org chart

Board & advisors

Teams

Research & Development Team

Leadership Team

Offices

Related companies